Latest Blogs

Jun 30, 2022
Establishing a reputation of humility, collegiality, and kindness ensures that people can seek you out earlier than later, which can prevent many complications and delays in care.
Jun 10, 2022
Dr. Khalid El Bairi reports on the educational presentations and exciting directions for future research from a recent event organized by young professionals in Taroudant, Morocco.
Jun 10, 2022
At the launch of an innovative partnership to combine medical oncology, hematology, and hospice and palliative medicine into a single fellowship program, Dr. Ramy Sedhom shares perspectives on the value of combined training and the critical function of this new training pathway.
May 26, 2022
"Several valuable lessons can be learned from the Syrian conflict and the immense experience of the Syrian American Medical Society’s (SAMS) efforts, coordination, and contributions developing oncology centers in northern Syria," said Dr. M. Bassel Atassi.
Subscribe to this column

Daniel F. Hayes, MD, FASCO, FACP

Daniel F. Hayes, MD, FACP, FASCO, is a Professor of Internal Medicine, the Stuart B. Padnos Professor in Breast Cancer, and the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center. An ASCO member since 1986, Dr. Hayes has served the Society in numerous volunteer capacities, including as 2016-2017 ASCO President. He is involved in several ASCO Expert Panels related to breast cancer. He served on the ASCO Board of Directors from 2011-2014, on the Conquer Cancer Foundation Grants Selection Committee, as Chair of the Scientific Program Committee, and on the Journal of Clinical Oncology Editorial Board. In 2007, he was presented with ASCO’s Gianni Bonadonna Breast Cancer Award and Lecture; in 2013, he was elected as a Fellow of ASCO (FASCO). Follow Dr. Hayes on Twitter @hoosierdfh.

Apr 07, 2017
We’re making progress in better understanding, and communicating, the many issues surrounding adverse events, although not as fast as we’d like. In the long run, our patients will benefit from all of these initiatives.
Mar 31, 2017
Sustaining this progress described in this report will be determined in large part by the level of federal investment in our nation's biomedical research enterprise.
Mar 16, 2017
ASCO soundly opposes President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health.
Mar 07, 2017
I am pleased to share the news that ASCO volunteers, staff, and collaborators are already making progress on major expansions to ASCO's programs to address global oncology priorities.
Jan 05, 2017
Do you belong to your ASCO State/Regional Affiliate? If not, you should! Do you take advantage of all they have to offer? If not, you should! You, and more importantly your patients, will benefit enormously.
Dec 22, 2016
The advent of rapid and relatively affordable high-throughput molecular analyses has permitted the development of a bewildering next generation of new cancer diagnostic tests that are being introduced into clinical care using our grandparents’ regulatory structure.

Pages